Medidata Solutions, Inc. (NASDAQ:MDSO) has been given a consensus rating of “Buy” by the fourteen ratings firms that are currently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $84.25.

A number of research analysts have recently weighed in on the stock. Royal Bank Of Canada reissued a “hold” rating and set a $80.00 price objective on shares of Medidata Solutions in a research note on Friday, October 27th. SunTrust Banks, Inc. reissued a “buy” rating and set a $92.00 price objective on shares of Medidata Solutions in a research note on Friday, October 27th. Wells Fargo & Company dropped their price objective on shares of Medidata Solutions from $83.00 to $80.00 and set a “market perform” rating for the company in a research note on Friday, October 27th. Zacks Investment Research raised shares of Medidata Solutions from a “sell” rating to a “hold” rating in a research note on Wednesday, September 20th. Finally, KeyCorp reissued a “buy” rating and set a $86.00 price objective on shares of Medidata Solutions in a research note on Sunday, September 17th.

COPYRIGHT VIOLATION WARNING: This piece was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://theolympiareport.com/2017/11/01/analysts-set-medidata-solutions-inc-mdso-pt-at-84-25.html.

Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings data on Thursday, October 26th. The company reported $0.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.31 by $0.02. Medidata Solutions had a net margin of 7.84% and a return on equity of 11.54%. The business had revenue of $140.08 million during the quarter, compared to analysts’ expectations of $141.27 million. During the same period last year, the company posted $0.28 EPS. The company’s revenue was up 16.7% on a year-over-year basis.

In other Medidata Solutions news, COO Michael L. Capone sold 5,000 shares of Medidata Solutions stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $74.53, for a total value of $372,650.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 5.80% of the stock is currently owned by insiders.

Several institutional investors and hedge funds have recently made changes to their positions in the business. Alps Advisors Inc. boosted its holdings in shares of Medidata Solutions by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 8,430 shares of the company’s stock valued at $659,000 after purchasing an additional 22 shares during the last quarter. 1st Global Advisors Inc. boosted its holdings in shares of Medidata Solutions by 0.5% in the 2nd quarter. 1st Global Advisors Inc. now owns 8,243 shares of the company’s stock valued at $645,000 after purchasing an additional 37 shares during the last quarter. World Asset Management Inc boosted its holdings in shares of Medidata Solutions by 1.2% in the 2nd quarter. World Asset Management Inc now owns 3,528 shares of the company’s stock valued at $276,000 after purchasing an additional 43 shares during the last quarter. State Board of Administration of Florida Retirement System boosted its holdings in shares of Medidata Solutions by 0.3% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 33,828 shares of the company’s stock valued at $2,645,000 after purchasing an additional 109 shares during the last quarter. Finally, Pinebridge Investments L.P. boosted its holdings in shares of Medidata Solutions by 2.1% in the 2nd quarter. Pinebridge Investments L.P. now owns 7,305 shares of the company’s stock valued at $572,000 after purchasing an additional 153 shares during the last quarter. Institutional investors own 98.49% of the company’s stock.

About Medidata Solutions

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Analyst Recommendations for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.